SMPD4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.362800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.843000E-01
Normal-vs-Stage2
9.482200E-01
Normal-vs-Stage3
5.488600E-01
Normal-vs-Stage4
6.660600E-01
Stage1-vs-Stage2
7.673600E-01
Stage1-vs-Stage3
4.692200E-01
Stage1-vs-Stage4
4.899000E-01
Stage2-vs-Stage3
1.988220E-01
Stage2-vs-Stage4
6.623000E-01
Stage3-vs-Stage4
3.210200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.043800E-01
Normal-vs-AfricanAmerican
6.099200E-01
Normal-vs-Asian
8.486000E-01
Caucasian-vs-AfricanAmerican
3.219000E-01
Caucasian-vs-Asian
8.248400E-01
AfricanAmerican-vs-Asian
3.897000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.453000E-01
Normal-vs-Female
9.208200E-01
Male-vs-Female
8.457600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.977800E-01
Normal-vs-Age(41-60Yrs)
6.634800E-01
Normal-vs-Age(61-80Yrs)
9.204200E-01
Normal-vs-Age(81-100Yrs)
8.583800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.156600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.988000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.491000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.806200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.267600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.190600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.917600E-01
Normal-vs-Daily Drinker
8.715200E-01
Normal-vs-Weekly Drinker
5.527800E-01
Normal-vs-Occasional Drinker
3.698800E-01
Normal-vs-Social Drinker
7.137000E-01
Non Drinker-vs-Daily Drinker
3.606200E-01
Non Drinker-vs-Weekly Drinker
8.225700E-02
Non Drinker-vs-Occasional Drinker
3.625900E-02
Non Drinker-vs-Social Drinker
2.552600E-01
Daily Drinker-vs-Weekly Drinker
3.100800E-01
Daily Drinker-vs-Occasional Drinker
2.587800E-01
Daily Drinker-vs-Social Drinker
6.941400E-01
Weekly Drinker-vs-Occasional Drinker
6.832400E-01
Weekly Drinker-vs-Social Drinker
4.518000E-01
Occasional Drinker-vs-Social Drinker
5.256600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.749600E-01
Normal-vs-Grade 2
9.093800E-01
Normal-vs-Grade 3
9.470600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.320800E-01
Grade 1-vs-Grade 3
9.275700E-02
Grade 1-vs-Grade 4
8.749600E-01
Grade 2-vs-Grade 3
2.047200E-01
Grade 2-vs-Grade 4
9.093800E-01
Grade 3-vs-Grade 4
9.470600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.448000E-01
Normal-vs-NonDiabetic
7.148000E-01
Diabetic-vs-NonDiabetic
3.187500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.428800E-01
Normal-vs-NoPancreatitis
9.237000E-01
Pancreatitis-vs-NoPancreatitis
3.016400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.351600E-01
Normal-vs-N1
9.564400E-01
N0-vs-N1
9.696200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.819000E-01
Normal-vs-TP53-NonMutant
8.326800E-01
TP53-Mutant-vs-TP53-NonMutant
1.947169999994E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
